Clinical Trial Update: Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of Ivarmacitinib as monotherapy for rheumatoid arthritis patients not adequately responding to csDMA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ivarmacitinib

Snippet

Sponsor: Tongji Hospital | Conditions: Rheumatoid Arthritis | Phase 4 | Status: NOT_YET_RECRUITING